AR044996A1 - 2-TIO-SUBSTITUTED BENZOTIOPHENE COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
2-TIO-SUBSTITUTED BENZOTIOPHENE COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- AR044996A1 AR044996A1 ARP040102337A ARP040102337A AR044996A1 AR 044996 A1 AR044996 A1 AR 044996A1 AR P040102337 A ARP040102337 A AR P040102337A AR P040102337 A ARP040102337 A AR P040102337A AR 044996 A1 AR044996 A1 AR 044996A1
- Authority
- AR
- Argentina
- Prior art keywords
- branched
- linear
- substituted
- alkyl
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- -1 carboxy, formyl Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: Compuestos de fórmula (1), en la cual: R1 representa un átomo de halógeno, un grupo alquilo (C1-6) lineal o ramificado o un grupo alcoxi (C1-6) lineal o ramificado; R2 representa un grupo fenilo no sustituido o sustituido por uno a tres grupos elegidos entre hidroxi, alquilo (C1-6) lineal o ramificado, alcoxi (C1-6) lineal o ramificado, carboxi, formilo, nitro, ciano, polihalogenoalquilo (C1-6) lineal o ramificado o átomos de halógeno; R3 representa un grupo alquilo (C1-6) lineal o ramificado sustituido o no sustituido, alquenilo (C1-6) lineal o ramificado no sustituido o sustituido, cicloalquilo (C3-8) o cicloalquil(C3-8)alquilo(C1-6) en el cual la parte alquilo puede ser lineal o ramificada, y se entiende que: el término "sustituido" aplicado a "alquilo" y "alquenilo" indica que estos grupos están sustituidos por uno o más átomos de halógeno, o por uno o más grupos elegidos entre hidroxi o alcoxi (C1-6) lineal o ramificado, sus enantiómeros y diastereoisómeros, así como también sus sales de adición con un ácido o con una base farmacéuticamente aceptable.Claim 1: Compounds of formula (1), wherein: R1 represents a halogen atom, a linear or branched (C1-6) alkyl group or a linear or branched (C1-6) alkoxy group; R2 represents a phenyl group unsubstituted or substituted by one to three groups selected from hydroxy, linear or branched (C1-6) alkyl, linear or branched (C1-6) alkoxy, carboxy, formyl, nitro, cyano, polyhalogenoalkyl (C1- 6) linear or branched or halogen atoms; R3 represents a substituted or unsubstituted linear or branched (C1-6) alkyl, unsubstituted or substituted linear or branched (C1-6) alkenyl, cycloalkyl (C3-8) or cycloalkyl (C3-8) alkyl (C1-6) alkyl group ) in which the alkyl part may be linear or branched, and it is understood that: the term "substituted" applied to "alkyl" and "alkenyl" indicates that these groups are substituted by one or more halogen atoms, or by one or more groups selected from linear or branched hydroxy or C1-6 alkoxy, their enantiomers and diastereoisomers, as well as their addition salts with an acid or with a pharmaceutically acceptable base.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0308214A FR2857011B1 (en) | 2003-07-04 | 2003-07-04 | NOVEL 2-THIOSUBSTITUTED BENZOTHIOPHENE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044996A1 true AR044996A1 (en) | 2005-10-12 |
Family
ID=33522784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102337A AR044996A1 (en) | 2003-07-04 | 2004-07-02 | 2-TIO-SUBSTITUTED BENZOTIOPHENE COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR044996A1 (en) |
| FR (1) | FR2857011B1 (en) |
| WO (1) | WO2005012282A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8476808B2 (en) | 2008-08-29 | 2013-07-02 | Michelin Recherche Et Technique | 1-d tire apparatus |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| ES2580702B1 (en) | 2015-02-25 | 2017-06-08 | Palobiofarma, S.L. | 2-Aminopyridine derivatives as adenosine A2b receptor antagonists and MT3 melatonin receptor ligands |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2738818B1 (en) * | 1995-09-18 | 1997-12-05 | Valentonine | NOVEL OXIDATION DERIVATIVES OF INDOLYLALKYLAMINES AND THEIR USE AS MEDICAMENTS |
| FR2772766B1 (en) * | 1997-12-24 | 2000-06-30 | Adir | NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2778662B1 (en) * | 1998-05-12 | 2000-06-16 | Adir | NOVEL SUBSTITUTED CYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
2003
- 2003-07-04 FR FR0308214A patent/FR2857011B1/en not_active Expired - Fee Related
-
2004
- 2004-06-30 WO PCT/FR2004/001676 patent/WO2005012282A1/en not_active Ceased
- 2004-07-02 AR ARP040102337A patent/AR044996A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005012282A1 (en) | 2005-02-10 |
| FR2857011A1 (en) | 2005-01-07 |
| FR2857011B1 (en) | 2005-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR061739A1 (en) | NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR063988A1 (en) | HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| UY28878A1 (en) | ARIL-O HETEROARILAMIDA ORTOSUSTITUTED AND COMPOSITION COMPOUNDS | |
| CO6321248A2 (en) | USEFUL TRIAZOL DERIVATIVES FOR THE TREATMENT OF DISEASES | |
| AR055150A1 (en) | ISOINDOL COMPOUNDS - IMIDO AND COMPOSITIONS THAT INCLUDE THEM AND THEIR METHODS OF USE | |
| AR061835A1 (en) | TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| UY28877A1 (en) | METHYL-ARIL OR HETEROARIL-AMIDA SUBSTITUTED COMPOUNDS AND COMPOSITIONS | |
| AR079205A1 (en) | MORPHOLINOTIAZOLS AS POSITIVE ALOSTERIC MODULATORS ALFA 7 | |
| AR056560A1 (en) | PIRROLOPIRIDINONES AS MODULATORS CB1 | |
| AR041883A1 (en) | PIRIDOPIRIMIDINONE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| UY28848A1 (en) | SELECTED CGRP ANTAGONISTS, PROCEDURES FOR THEIR PREPARATION, AND THEIR EMPLOYMENT AS MEDICATIONS | |
| DOP2006000045A (en) | DERIVATIVES OF (1,5-DIFENIL-1H-PIRAZOL-3-IL OXADIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
| PA8589801A1 (en) | AMINOALCOXYINDOLS | |
| AR068373A1 (en) | DERIVATIVES OF N-PHENYLACETAMIDE, INHIBITORS OF THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | |
| AR072103A1 (en) | DERIVATIVES OF (PIPERAZINILO WITH BRIDGE LINKS) -1- ALCANONA, ITS USE AS P75 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR068372A1 (en) | DERIVATIVES OF N-PHENYLACETAMIDE, INHIBITORS OF THE ENZYME SOAT1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | |
| AR044996A1 (en) | 2-TIO-SUBSTITUTED BENZOTIOPHENE COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR054747A1 (en) | INDANIL-PIPERAZINE COMPOUNDS A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR054121A1 (en) | PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3 | |
| AR031438A1 (en) | CICLOHEXIL (RENT) -PROPANOLAMINS, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR044672A1 (en) | BENZOTIAZINE AND BENZOTIADIAZINE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR074629A1 (en) | DERIVATIVES OF 1-BENCIL-CINOLIN-4- (1H) -ONA SUBSTITUTED, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS AND ITS USE IN THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH RECEPTORS OF THE CANNABINOIDS CB2 | |
| AR050542A1 (en) | IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MX2009004007A (en) | NEW DERIVATIVES OF INDOL, PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| AR040276A1 (en) | DERIVATIVES OF 3- (4-OXO-4H-CROMEN-2-IL) - (1H) -QUINOLEIN-4-ONAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |